A surprise discovery may have saved one of the world’s oldest chemical companies from sliding into irrelevance.
This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.
Read at original outlet ↗
BAGANBAZAR GRAPHSource-attributed newsWORLD deskIndia's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceutical Industries and Aurobindo Pharma are likely to report good growth. In contrast, Dr Reddy's Laboratories and Lupin may face challenges due to increased competition and a high base. Pricing pressure and elevated raw material costs are also expected to impact overall performance.
BAGANBAZAR GRAPHSource-attributed newsWORLD deskInternational investors have raised concerns regarding the Indian Income-tax authorities' invocation of the judicial anti-avoidance rule. At a recent meeting, investors communicated their issues with the Central Board of Direct Taxes on this matter. The use of JAAR to deny relief on grandfathered shares contradicts prior regulations established by the CBDT. The standing of both GAAR and JAAR remains complex due to Supreme Court rulings.
BAGANBAZAR GRAPHSource-attributed newsWORLD deskNifty gained 3% last week, forming a higher-top and higher-bottom structure, indicating bullish sentiment. Analysts suggest it must breach key resistance levels for more substantial gains ahead. Meanwhile, Bank Nifty is approaching significant resistance, which may hinder further upside potential shortly. Key stocks like Coforge, Kotak Bank, and Indian Hotels present buying opportunities based on technical analysis.